l-Asparaginase-Induced Antithrombin Type I Deficiency
Authors:
- Antonia MiñanoAMAntonia Miñano
- Constantino MartínezCMConstantino Martínez
- Elena Pérez-CeballosEPElena Pérez-Ceballos
- Inmaculada HerasIHInmaculada Heras
- José L. FusterJFJosé L. Fuster
- Vicente VicenteVVVicente Vicente
- Javier CorralJCJavier Corral
- 1 July 2006
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 169 (1) , 142-153
Abstract
No abstract availableKeywords
Funding Information
- Fundación Séneca (00583/PI/04, SAF2003-00840)
This publication has 40 references indexed in Scilit:
- Latent antithrombin and its detection, formation and turnover in the circulationJournal of Thrombosis and Haemostasis, 2004
- Hepatocellular carcinoma with nonalcoholic steatohepatitisJournal of Gastroenterology, 2004
- Measurement of Plasma Ammonia Is Affected in Patients Receiving Asparaginase TherapyClinical Chemistry, 2003
- Gliap − a novel untypical l‐asparaginase localized to rat brain astrocytesJournal of Neurochemistry, 2003
- Serpin Polymerization Is Prevented by a Hydrogen Bond Network That Is Centered on His-334 and Stabilized by GlycerolJournal of Biological Chemistry, 2003
- Mallory body—A disease-associated type of sequestosomeHepatology, 2002
- Conformational diseaseThe Lancet, 1997
- ANTITHROMBIN III DEFICIENCY DURING ASPARAGINASE THERAPYThe Lancet, 1980
- L‐asparaginase effect on antithrombin‐III levelsMedical and Pediatric Oncology, 1979
- L‐Asparaginase: A Review1973